- Report
- March 2023
- 71 Pages
Italy
From €2726EUR$2,995USD£2,337GBP
- Report
- March 2023
- 71 Pages
France
From €2726EUR$2,995USD£2,337GBP
- Report
- March 2023
- 71 Pages
United Kingdom
From €2726EUR$2,995USD£2,337GBP
- Report
- March 2023
- 71 Pages
United States
From €2726EUR$2,995USD£2,337GBP
- Book
- September 2014
- 1880 Pages
- Book
- January 2007
- 488 Pages
- Book
- April 2024
- 304 Pages
- Book
- June 2021
- 592 Pages
- Book
- April 2020
- 336 Pages
- Book
- April 2019
- 816 Pages
- Book
- July 2018
- 832 Pages
- Book
- January 2017
- 504 Pages
- Book
- September 2016
- 680 Pages
- Book
- May 2016
- 288 Pages
- Book
- March 2015
- 352 Pages
- Book
- October 2013
- 624 Pages
- Book
- October 2012
- 456 Pages
- Book
- August 2012
- 112 Pages
- Book
- April 2012
- 1272 Pages

The Liver Transplantation market within the context of Biotechnology is a rapidly growing field of medical research and development. It involves the transplantation of a healthy liver from a donor into a patient with a diseased or damaged liver. This procedure is used to treat a variety of liver diseases, including cirrhosis, hepatitis, and liver cancer. The transplantation process involves the removal of the diseased liver and the replacement of it with a healthy donor liver. The donor liver is then connected to the patient's blood vessels and bile ducts, allowing the patient to receive the donor liver's healthy cells and nutrients.
The Liver Transplantation market is driven by advances in medical technology, such as the development of new surgical techniques and the use of immunosuppressant drugs to reduce the risk of organ rejection. Additionally, the increasing prevalence of liver diseases and the growing demand for organ transplants are contributing to the growth of the market.
Some of the major companies in the Liver Transplantation market include Astellas Pharma, Novartis, Roche, and Johnson & Johnson. Show Less Read more